Pharmaceutical Executive
December 18, 2019
Features
39
12
Renewed education efforts by employers, however, are slowly helping them take back decision-making reins in their engagements with pharma.
December 17, 2019
Features
39
12
Lundbeck executive Taj Bhardwaj talks about the differing mindsets necessary to lead local and global-level market access strategy in pharma-and how his current company is committed to stay in the fight to advance new treatments and break down stigmas in mental health.
December 17, 2019
Features
39
12
Exploring the roadmap for US-based, R&D-focused biopharma companies seeking to successfully penetrate product markets and reach patients in Europe.
December 17, 2019
Features
39
12
Industry working group identifies the value characteristics that may, collectively, become part of a shared approach to valuing pharmaceutical treatments.
December 16, 2019
From the Editor
39
12
With so many different rationales for drug pricing and “value” continuing to feed the debate, the market access function in healthcare must clearly tackle these issues-but at what cost to the patient?
December 13, 2019
Features
39
12
The industry’s quest to get a handle on the cost-shift implications of these new programs and the risks for patient access and pharma’s bottom line.
December 12, 2019
Columns
39
12
Sponsors developed important new therapies amidst ongoing concerns over drug quality and costs.
December 11, 2019
Columns
39
12
European Commission working group is looking closely at marketing obligations for centrally authorized products.
December 01, 2019
Columns
39
12
Gauging physician awareness of nucleic acid-based therapies.
December 01, 2019
Issue PDF
39
12
Click the title above to open the Pharmaceutical Executive December 2019 issue in an interactive PDF format.
December 01, 2019
Special Sponsored Section
39
12
More than two years since the devastation inflicted by Hurricane Maria, Puerto Rico’s supply of medical products has remained largely uninterrupted, debunking common misconceptions at the time and maintaining the island’s standing as one of the most attractive life sciences manufacturing hubs.